My first earnings short-squeeze trade idea is entrepreneurial pharmaceutical company Ironwood Pharmaceuticals (IRWD), which is set to release numbers on Tuesday before the market open. Wall Street analysts, on average, expect Ironwood Pharmaceuticals to report revenue of $16.85 million on a loss of 49 cents per share.
If you're looking for a heavily shorted stock that's uptrending strongly heading into its quarterly report, then make sure to check out shares of Ironwood Pharmaceuticals. During the last month, this stock has soared by 35% and shares are now trading just one point off its 52-week high of $15.92 a share.The current short interest as a percentage of the float for Ironwood Pharmaceuticals is rather high at 14.3%. That means that out of the 91.96 million shares in the tradable float, 10.80 million shares are sold short by the bears. The bears have also been increasing their bets from the last reporting period by 5%, or by about 510,000 shares. If the bears are caught leaning too hard into this quarter, then we could see a large short-squeeze develop post-earnings. From a technical perspective, IRWD is currently trending above both it 50-day and 200-day moving averages, which is bullish. This stock has been soaring during the last month, with shares moving higher from its low of $10.36 to its recent high of $14.74 a share. During that move, shares of IRWD have been consistently making higher lows and higher highs, which is bullish technical price action. That move has now pushed IRWD within range of triggering a near-term breakout trade post-earnings. If you're bullish on IRWD, then I would wait until after its report and look for long-biased trades if this stock manages to break out above some near-term overhead resistance levels at $14.74 to $15 a share and then once it clears its 52-week high of $15.92 a share with high volume. Look for volume on that move that hits near or above its three-month average action of 616,062 shares. If that breakout hits, then IRWD will set up to re-test or possibly take out its next major overhead resistance level at $16.50 a share. I would simply avoid IRWD or look for short-biased trades if after earnings it fails to trigger that breakout, and then drops back below some near-term support at $14 a share with heavy volume. If we get that move, then IRWD will set up to re-test or possibly take out its 200-day moving average of $12.50 a share.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV